EUVIMEDEUVIMED entdecken
Open Access

DRIMS: A Synthetic Biology Platform that Enables Deletion, Replacement, Insertion, Mutagenesis, and Synthesis of DNA

Leidy D Caraballo G, Inci Cevher Zeytin iD, Purva Rathi, Che-Hsing Li, Ai-Ni Tsao, Yaery J Salvador L, Manish Ranjan, Brendan Magee Traynor, Andras A Heczey iD

ACS Synthetic Biology · 2025

DOI: 10.1021/acssynbio.4c00649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, 2025. Verfasst von Leidy D Caraballo G und 8 weiteren Autor:innen. Beteiligte Einrichtung: Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas 77030, United States. Hauptthemen laut MEDLINE: Synthetic Biology, DNA, Genetic Engineering. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Alex's Lemonade Stand Foundation for Childhood Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Synthetic BiologyDNAGenetic EngineeringMutagenesisPolymerase Chain ReactionMutagenesis, InsertionalSequence Deletion

Stichwörter der Autor:innen

DNA cloningDNA synthesisPCRchimeric antigen receptor (CAR)genetic engineeringmutagenesis

Substanzen

DNA

Autor:innen und Institutionen

  • Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas 77030, United States.
  • Division of Pediatric Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, United States.
  • Center for Advanced Innate Cell Therapy, Texas Children's Hospital, Houston, Texas 77030, United States.
  • Program in Immunology & Microbiology, Baylor College of Medicine, Houston, Texas 77030, United States.
  • Program in Cancer & Cell Biology, Baylor College of Medicine, Houston, Texas 77030, United States.

ORCID-Profile: Inci Cevher Zeytin, Andras A Heczey

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Alex's Lemonade Stand Foundation for Childhood Cancer
  • Advanced Innate Cell Therapy of Texas Children?s Cancer Center

Zitieren

APA

Caraballo G, L. D., Cevher Zeytin, I., Rathi, P., Li, C. H., Tsao, A. N., Salvador L, Y. J., Ranjan, M., Traynor, B. M., & Heczey, A. A. (2025). DRIMS: A Synthetic Biology Platform that Enables Deletion, Replacement, Insertion, Mutagenesis, and Synthesis of DNA. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.4c00649

Vancouver

Caraballo G LD, Cevher Zeytin I, Rathi P, Li CH, Tsao AN, Salvador L YJ, et al. DRIMS: A Synthetic Biology Platform that Enables Deletion, Replacement, Insertion, Mutagenesis, and Synthesis of DNA. ACS Synthetic Biology. 2025. doi:10.1021/acssynbio.4c00649

BibTeX
@article{CaraballoG2025,
  author = {Caraballo G, Leidy D and Cevher Zeytin, Inci and Rathi, Purva and Li, Che-Hsing and Tsao, Ai-Ni and Salvador L, Yaery J and Ranjan, Manish and Traynor, Brendan Magee and Heczey, Andras A},
  title = {DRIMS: A Synthetic Biology Platform that Enables Deletion, Replacement, Insertion, Mutagenesis, and Synthesis of DNA},
  journal = {ACS Synthetic Biology},
  year = {2025},
  doi = {10.1021/acssynbio.4c00649}
}
Kostenlos starten →